Baxter Cash on Hand 2010-2025 | BAX
Baxter cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- Baxter cash on hand for the quarter ending March 31, 2025 was $2.294B, a 24.19% decline year-over-year.
- Baxter cash on hand for 2024 was $1.764B, a 42.69% decline from 2023.
- Baxter cash on hand for 2023 was $3.078B, a 79.16% increase from 2022.
- Baxter cash on hand for 2022 was $1.718B, a 41.78% decline from 2021.
| Baxter Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $1,764 |
| 2023 | $3,078 |
| 2022 | $1,718 |
| 2021 | $2,951 |
| 2020 | $3,730 |
| 2019 | $3,335 |
| 2018 | $1,838 |
| 2017 | $3,394 |
| 2016 | $2,801 |
| 2015 | $7,361 |
| 2014 | $2,925 |
| 2013 | $2,733 |
| 2012 | $3,270 |
| 2011 | $2,905 |
| 2010 | $2,685 |
| 2009 | $2,786 |
| Baxter Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2025-03-31 | $2,294 |
| 2024-12-31 | $1,764 |
| 2024-09-30 | $1,420 |
| 2024-06-30 | $2,095 |
| 2024-03-31 | $3,026 |
| 2023-12-31 | $3,078 |
| 2023-09-30 | $5,788 |
| 2023-06-30 | $1,722 |
| 2023-03-31 | $1,673 |
| 2022-12-31 | $1,718 |
| 2022-09-30 | $1,601 |
| 2022-06-30 | $1,852 |
| 2022-03-31 | $2,294 |
| 2021-12-31 | $2,951 |
| 2021-09-30 | $3,258 |
| 2021-06-30 | $3,136 |
| 2021-03-31 | $3,182 |
| 2020-12-31 | $3,730 |
| 2020-09-30 | $4,359 |
| 2020-06-30 | $4,085 |
| 2020-03-31 | $4,110 |
| 2019-12-31 | $3,335 |
| 2019-09-30 | $3,009 |
| 2019-06-30 | $2,925 |
| 2019-03-31 | $1,908 |
| 2018-12-31 | $1,838 |
| 2018-09-30 | $2,860 |
| 2018-06-30 | $2,857 |
| 2018-03-31 | $2,947 |
| 2017-12-31 | $3,394 |
| 2017-09-30 | $3,517 |
| 2017-06-30 | $3,817 |
| 2017-03-31 | $2,858 |
| 2016-12-31 | $2,801 |
| 2016-09-30 | $2,597 |
| 2016-06-30 | $2,630 |
| 2016-03-31 | $3,443 |
| 2015-12-31 | $7,361 |
| 2015-09-30 | $6,126 |
| 2015-06-30 | $6,680 |
| 2015-03-31 | $2,530 |
| 2014-12-31 | $2,925 |
| 2014-09-30 | $2,078 |
| 2014-06-30 | $1,866 |
| 2014-03-31 | $2,049 |
| 2013-12-31 | $2,733 |
| 2013-09-30 | $2,376 |
| 2013-06-30 | $5,989 |
| 2013-03-31 | $2,689 |
| 2012-12-31 | $3,270 |
| 2012-09-30 | $3,191 |
| 2012-06-30 | $2,353 |
| 2012-03-31 | $2,272 |
| 2011-12-31 | $2,905 |
| 2011-09-30 | $2,338 |
| 2011-06-30 | $2,018 |
| 2011-03-31 | $2,168 |
| 2010-12-31 | $2,685 |
| 2010-09-30 | $2,788 |
| 2010-06-30 | $2,300 |
| 2010-03-31 | $2,673 |
| 2009-12-31 | $2,786 |
| 2009-09-30 | $2,571 |
| 2009-06-30 | $1,802 |
| 2009-03-31 | $1,703 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $15.842B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.294B | 27.81 |
| Boston Scientific (BSX) | United States | $157.073B | 39.32 |
| Stryker (SYK) | United States | $146.485B | 30.63 |
| EssilorLuxottica (ESLOY) | France | $131.510B | 0.00 |
| Medtronic (MDT) | Ireland | $104.117B | 14.76 |
| Haleon (HLN) | United Kingdom | $50.587B | 28.80 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.544B | 0.00 |
| ResMed (RMD) | United States | $36.103B | 27.12 |
| GE HealthCare Technologies (GEHC) | United States | $32.514B | 15.44 |
| Agilent Technologies (A) | United States | $31.721B | 20.95 |
| Terumo (TRUMY) | Japan | $28.131B | 36.54 |
| Insulet (PODD) | United States | $22.987B | 90.23 |
| Koninklijke Philips (PHG) | Netherlands | $21.694B | 15.60 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.639B | 11.97 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.666B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.269B | 21.81 |
| Lantheus Holdings (LNTH) | United States | $5.242B | 13.22 |
| Prestige Consumer Healthcare (PBH) | United States | $4.244B | 18.96 |
| Perrigo (PRGO) | Ireland | $3.757B | 9.52 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.266B | 14.88 |
| ICU Medical (ICUI) | United States | $3.210B | 23.67 |
| Envista Holdings (NVST) | United States | $3.051B | 25.35 |
| GN Store Nord (GNNDY) | Denmark | $2.163B | 17.92 |
| QuidelOrtho (QDEL) | United States | $2.114B | 14.54 |
| LeMaitre Vascular (LMAT) | United States | $1.868B | 41.76 |
| AtriCure (ATRC) | United States | $1.683B | 0.00 |
| Neogen (NEOG) | United States | $1.335B | 17.08 |
| Acuren (TIC) | United States | $1.317B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.256B | 12.75 |
| Kestra Medical Technologies (KMTS) | United States | $1.156B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.120B | 25.19 |
| BioLife Solutions (BLFS) | United States | $1.057B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.991B | 12.67 |
| InMode (INMD) | Israel | $0.919B | 9.26 |
| Evolus (EOLS) | United States | $0.633B | 0.00 |
| CeriBell (CBLL) | United States | $0.625B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.590B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.568B | 0.00 |
| Valneva SE (VALN) | France | $0.534B | 0.00 |
| Owens & Minor (OMI) | United States | $0.509B | 4.22 |
| Capricor Therapeutics (CAPR) | United States | $0.479B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.446B | 0.00 |
| Surmodics (SRDX) | United States | $0.412B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.324B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.323B | 11.86 |
| Canopy Growth (CGC) | Canada | $0.313B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.307B | 54.70 |
| Sanara MedTech (SMTI) | United States | $0.274B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.261B | 22.00 |
| ZimVie (ZIMV) | United States | $0.245B | 11.11 |
| Cerus (CERS) | United States | $0.241B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.239B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.237B | 0.00 |
| Biote (BTMD) | United States | $0.223B | 6.28 |
| TriSalus Life Sciences (TLSI) | United States | $0.212B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.207B | 0.00 |
| Brainsway (BWAY) | Israel | $0.201B | 53.25 |
| Quanterix (QTRX) | United States | $0.197B | 0.00 |
| Omeros (OMER) | United States | $0.186B | 0.00 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Organigram Global (OGI) | Canada | $0.179B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 14.46 |
| Exagen (XGN) | United States | $0.145B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 16.69 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.094B | 0.00 |
| Agape ATP (ATPC) | $0.092B | 0.00 | |
| Fonar (FONR) | United States | $0.089B | 11.42 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Zynex (ZYXI) | United States | $0.078B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.076B | 0.00 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Apyx Medical (APYX) | United States | $0.067B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.060B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 0.00 |
| United Health Products (UEEC) | United States | $0.052B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.051B | 0.00 |
| Modular Medical (MODD) | United States | $0.047B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 13.47 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.031B | 41.86 |
| Safety Shot (SHOT) | United States | $0.029B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |